Ameritas Investment Partners’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97.7K | Buy |
5,598
+777
| +16% | +$13.6K | ﹤0.01% | 1777 |
|
|
2025
Q1 | $60.6K | Hold |
4,821
| – | – | ﹤0.01% | 1994 |
|
|
2024
Q4 | $50.9K | Hold |
4,821
| – | – | ﹤0.01% | 2172 |
|
|
2024
Q3 | $69.9K | Hold |
4,821
| – | – | ﹤0.01% | 1996 |
|
|
2024
Q2 | $41K | Buy |
4,821
+2,819
| +141% | +$24K | ﹤0.01% | 2246 |
|
|
2024
Q1 | $20.5K | Hold |
2,002
| – | – | ﹤0.01% | 2554 |
|
|
2023
Q4 | $11K | Hold |
2,002
| – | – | ﹤0.01% | 2819 |
|
|
2023
Q3 | $7.57K | Hold |
2,002
| – | – | ﹤0.01% | 2907 |
|
|
2023
Q2 | $13.4K | Buy |
+2,002
| New | +$13.4K | ﹤0.01% | 2780 |
|
|
2022
Q2 | – | Sell |
-1,032
| Closed | -$4K | – | 3222 |
|
|
2022
Q1 | $4K | Hold |
1,032
| – | – | ﹤0.01% | 3007 |
|
|
2021
Q4 | $7K | Hold |
1,032
| – | – | ﹤0.01% | 2993 |
|
|
2021
Q3 | $10K | Hold |
1,032
| – | – | ﹤0.01% | 2941 |
|
|
2021
Q2 | $32K | Hold |
1,032
| – | – | ﹤0.01% | 2469 |
|
|
2021
Q1 | $45K | Buy |
+1,032
| New | +$45K | ﹤0.01% | 2147 |
|